Sellas Life Sciences Group Inc (NASDAQ:SLS)

5.26
Delayed Data
As of May 24
 -0.44 / -7.72%
Today’s Change
3.43
Today|||52-Week Range
19.41
-36.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues9.3M0.000.000.00
 
 
Cost of Goods Sold954.0K0.000.000.00
 
 
Depreciation And Amortization889.0K355.0K142.0K0.00
 
 
 
 
 
Operating ExpensesGross Income7.5M-355.0K-142.0K0.00
 
 
 
 
General Expenses57.7M33.9M31.7M15.5M
 
 
 
 
 
Research And Development28.4M23.6M19.9M6.1M
 
 
 
 
 
Total Operating Expenses59.5M34.2M31.9M15.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-50.2M-34.2M-31.9M-15.5M
 
 
 
 
 
Extraordinary Credit16.7M1.7M27.3M0.00
 
 
 
 
Extraordinary Charge-2.0M-5.3M-2.8M-7.6M
 
 
 
 
 
Interest Expense On Debt1.1M760.0K3.5M462.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-36.6M-38.6M-10.9M-23.5M
 
 
 
 
 
Income Taxes0.00-365.0K-243.0K-253.0K
 
 
 
 
Discontinued Operations0.00-20.4M-12.4M0.00
 
 
 
Extraordinary Items0.00-4.5M0.000.00
 
 
Net Income-36.6M-59.4M-23.5M-24.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS199.0K258.8K332.0K78.0K
 
 
 
 
 
Shares To Calculate EPS Diluted199.0K258.8K332.0K78.0K
 
 
 
 
 
 
Earnings Per ShareEPS-$186.00-$246.00-$70.80-$313.20
 
 
 
 
 
EPS Diluted-$186.00-$229.36-$70.94-$313.20